Orasure Technologies (OSUR) Accumulated Expenses (2010 - 2025)
Orasure Technologies (OSUR) posted Accumulated Expenses of $11.1 million for Q4 2025, down 12.0% sequentially from $12.7 million in Q3 2025, and down 44.75% YoY from $20.2 million in Q4 2024.
Orasure Technologies (OSUR) Accumulated Expenses (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Accumulated Expenses for 16 years, with the latest figure at $11.1 million in Q4 2025.
- Quarterly Accumulated Expenses fell 44.75% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (down 44.75% YoY) and the FY2025 annual result came in at $11.1 million, down 44.75% from the prior year.
- Accumulated Expenses retreated to $11.1 million in Q4 2025 per OSUR's latest filing, from $12.7 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $33.8 million in Q4 2021 and troughed at $11.1 million in Q4 2025.
- A 5-year average of $19.6 million and a median of $20.7 million in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2025: Accumulated Expenses jumped 51.97% in 2021, then sank 44.75% in 2025.
- Over 5 years, Accumulated Expenses stood at $33.8 million in 2021, then fell by 23.73% to $25.8 million in 2022, then retreated by 11.85% to $22.7 million in 2023, then fell by 11.14% to $20.2 million in 2024, then tumbled by 44.75% to $11.1 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $11.1 million, $12.7 million, and $14.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.15 Mn |
| Sep 30, 2025 | 12.67 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 20.18 Mn |
| Sep 30, 2024 | 15.01 Mn |
| Jun 30, 2024 | 16.20 Mn |
| Mar 31, 2024 | 12.72 Mn |
| Dec 31, 2023 | 22.71 Mn |
| Sep 30, 2023 | 21.14 Mn |
| Jun 30, 2023 | 23.81 Mn |
| Mar 31, 2023 | 22.67 Mn |
| Dec 31, 2022 | 25.76 Mn |
| Sep 30, 2022 | 25.41 Mn |
| Jun 30, 2022 | 23.17 Mn |
| Mar 31, 2022 | 21.91 Mn |
| Dec 31, 2021 | 33.78 Mn |
| Sep 30, 2021 | 22.61 Mn |
| Jun 30, 2021 | 16.90 Mn |
| Mar 31, 2021 | 17.00 Mn |